The choice of frontline therapy for a patient with chronic phase chronic myeloid leukemia (CP-CML) can have a profound effect on the long-term clinical outcome. Currently, five tyrosine kinase ...

In 2018, three back-to-back publications unraveled the role of the gut microbiota—a rich organ within the gastrointestinal tract primarily composed of 10 13 commensal bacteria—in modulating ICI ...

Establishing the Philippine Cancer Center National Cancer Research Agenda 2024-2028: Insights and Future Directions Health care in Jordan is relatively advanced, with a mix of public and private ...

Empowering the Next Generation of Cancer Research Advocates: Community Engagement Across the Research Continuum Multicancer early detection tests (MCEDs), sometimes referred to as liquid biopsies, are ...

The global discourse surrounding ENDS has generated insightful perspectives, but these may not fully align with the realities of LMICs still battling higher (than global average) tobacco use rates.

Which Is the Best Tyrosine Kinase Inhibitor for Newly Diagnosed Chronic Myelogenous Leukemia? Chronic lymphocytic leukemia (CLL) remains an incurable disease, except in rare cases treated with ...

A cross-sectional survey was conducted at a tertiary academic pediatric center in Toronto, Canada. English-speaking pediatric patients with cancer age 12 years and older, as well as their caregivers, ...

Palliative Radiotherapy Near the End of Life: An Analysis of Factors Influencing the Administration of Radiotherapy in Advanced Tumor Disease This multicenter retrospective study included patients ...

State of the Art: Personalizing Treatment for Patients With Metastatic Castration-Resistant Prostate Cancer Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer, where the endemic subtype ...

Scoping Review of the Impact of Culture on the Effectiveness of Quality Improvement Programs CNS metastases (CNSms) are common clinical events in patients with solid ...

Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not? The following represents disclosure information provided by authors of this manuscript. All relationships are ...

Typically, ICIs are administered in infusion centers or clinics, where their cost is covered by outpatient prescription drug coverage plans. Yet, hospitalizations are common among patients with cancer ...